Nick Morrell (@nickmorrell15) 's Twitter Profile
Nick Morrell

@nickmorrell15

Clinician scientist, lung doc, co-Founder of Morphogen-IX and Interact Bio Ltd, developing better treatments for pulmonary arterial hypertension.

ID: 1005449347260133376

linkhttp://www.med.cam.ac.uk/morrell/ calendar_today09-06-2018 13:59:39

850 Tweet

1,1K Followers

690 Following

Nick Morrell (@nickmorrell15) 's Twitter Profile Photo

Honoured to host HRH Duchess of Gloucester at our official opening of the Cambridge Heart and Lung Research Institute yesterday. Now the real work begins to undertake high impact translational science to benefit patients with cardiopulmonary conditions! @BHF Royal Papworth Hospital NHS FT đź’™

Honoured to host HRH Duchess of Gloucester at our official opening of the Cambridge Heart and Lung Research Institute yesterday. Now the real work begins to undertake high impact translational science to benefit patients with cardiopulmonary conditions! @BHF <a href="/RoyalPapworth/">Royal Papworth Hospital NHS FT đź’™</a>
Mauro Lago-Docampo (@murulago) 's Twitter Profile Photo

Our TBX4 paper has just been accepted for publication in ATS Blue Journal !! Happy of having shared this scientific journey with so many giants in the field! Official twit when we have it online 🥳🥳🥳🥳

Nick Morrell (@nickmorrell15) 's Twitter Profile Photo

The peppered moth - never actually seen one in real life before (although this one sadly dead). One of the first evolutionary stories we heard at school featured this beautiful creature.

The peppered moth - never actually seen one in real life before (although this one sadly dead). One of the first evolutionary stories we heard at school featured this beautiful creature.
Charmaine Griffiths (@icharmaine) 's Twitter Profile Photo

Today is a historic day for British Heart Foundation, as we announce #CureHeart as the winner of our £30m #BigBeatChallenge 🔬 I'm unbelievably proud that this incredible research, funded by our amazing supporters, could lead to the first cures for people with inherited muscle heart diseases

JonnyFinlay (@finlay_jonny) 's Twitter Profile Photo

LockBody is hiring! Looking for talented, passionate scientists who want to change the future of cancer therapy: centessa.com/career-details/

Centessa Pharmaceuticals (@centessa) 's Twitter Profile Photo

Thrilled to announce that US Orphan Drug designation was granted to SerpinPC, our novel inhibitor of activated protein C, being investigated as a treatment of #hemophiliaB. We look forward to initiating registrational studies for SerpinPC later this year. bit.ly/3eDNx50

Thrilled to announce that US Orphan Drug designation was granted to SerpinPC, our novel inhibitor of activated protein C, being investigated as a treatment of #hemophiliaB. We look forward to initiating registrational studies for SerpinPC later this year. bit.ly/3eDNx50
Centessa Pharmaceuticals (@centessa) 's Twitter Profile Photo

Today we announced a poster presentation of data from our oral small-molecule orexin receptor 2 (OX2R) agonist discovery pipeline at #SleepEurope 2022. The poster will be presented in Athens on Thurs., Sept. 29 at 12:15pm EEST. Read our press release: investors.centessa.com/news-releases/…

David Grainger (@sciencescanner) 's Twitter Profile Photo

Fantastic to see RxCelerate Founder and CEO, Jill Reckless, featured in Sunday Times! bit.ly/3UQ4utV Jill has been an inspiration to just about everyone she has ever worked with

Montani David (@montanidavid) 's Twitter Profile Photo

Great job of the International Consortium for Genetic Studies in PAH. Proud to be part of this dynamic team. @Pulmotension @Respifil InsermU999 Genetic counselling and testing in pulmonary arterial hypertension - A consensus statement erj.ersjournals.com/content/early/…

Great job of the International Consortium for Genetic Studies in PAH. Proud to be part of this dynamic team. @Pulmotension @Respifil <a href="/InsermU999/">InsermU999</a> 

Genetic counselling and testing in pulmonary arterial hypertension - A consensus statement
erj.ersjournals.com/content/early/…
Centessa Pharmaceuticals (@centessa) 's Twitter Profile Photo

It's #PulmonaryHypertension Awareness Month. Centessa's advancing MGX292 as part of our mission to develop transformational medicines for patients with #PulmonaryArterialHypertension. Visit The Pulmonary Hypertension Association to learn more about PH Awareness month: bit.ly/3De9YGN

It's #PulmonaryHypertension Awareness Month. Centessa's advancing MGX292 as part of our mission to develop transformational medicines for patients with #PulmonaryArterialHypertension. Visit <a href="/PHAssociation/">The Pulmonary Hypertension Association</a> to learn more about PH Awareness month: bit.ly/3De9YGN
Centessa Pharmaceuticals (@centessa) 's Twitter Profile Photo

Today we announced that new data from an additional 18-months of continued treatment with SerpinPC from the OLE of our Phase 2a Study of SerpinPC in hemophilia was accepted for oral presentation at the 64th ASH Annual Meeting on Sat., Dec. 10 at 2:15pm CT. investors.centessa.com/news-releases/…

Today we announced that new data from an additional 18-months of continued treatment with SerpinPC from the OLE of our Phase 2a Study of SerpinPC in hemophilia was accepted for oral presentation at the 64th ASH Annual Meeting on Sat., Dec. 10 at 2:15pm CT. investors.centessa.com/news-releases/…
TBX4Life (@tbx4_life) 's Twitter Profile Photo

Amazing Accomplishment: our first joint paper is published in Blue Journal ATS Blue Journal !! Huge Thanks to all contributors and especially to Justyna Karolak for the leadership! Big research value, but also huge increase of credibility for TBX4Life! #tbx4 atsjournals.org/doi/abs/10.116…

Amazing Accomplishment: our first joint paper is published in Blue Journal <a href="/ATSBlueEditor/">ATS Blue Journal</a> !! Huge Thanks to all contributors and especially to Justyna Karolak for the leadership! Big research value, but also huge increase of credibility for TBX4Life! #tbx4
atsjournals.org/doi/abs/10.116…
Alex Ainscough (@ainscoughalex) 's Twitter Profile Photo

Proud moment! My First, First Author paper is finally published! Happy Monday News! 🥳 An organ-on-chip model of pulmonary arterial hypertension identifies a BMPR2-SOX17-prostacyclin signalling axis ➡️nature.com/articles/s4200… Communications Biology #PAH #PhD #PhDChat Here's the Tweetorial👇

Centessa Pharmaceuticals (@centessa) 's Twitter Profile Photo

Centessa hosted The Pulmonary Hypertension Association & individuals living with PH for an event to raise awareness of this complex disease. Learn how you can help spread awareness #PulmonaryArterialHypertension.

Centessa hosted <a href="/PHAssociation/">The Pulmonary Hypertension Association</a> &amp; individuals living with PH for an event to raise awareness of this complex disease. Learn how you can help spread awareness #PulmonaryArterialHypertension.
Centessa Pharmaceuticals (@centessa) 's Twitter Profile Photo

Join Centessa and the Rare Disease community to help raise awareness of #RareDisease. Show your stripes in honor of #RareDiseaseDay and visit @RareDisease's website to get involved: bit.ly/3ZRqSFx

Join Centessa and the Rare Disease community to help raise awareness of #RareDisease. Show your stripes in honor of #RareDiseaseDay and visit @RareDisease's website to get involved: bit.ly/3ZRqSFx
Charlotte Summers (@charlot_summers) 's Twitter Profile Photo

We have had lots of fun this morning celebrating the announcement of a ÂŁ16 million gift to HLRI and are thrilled to change our name in honour of our generous benefactor. We are grateful to Victor & our other wonderful partners incl British Heart Foundation Royal Papworth Hospital Charity Cystic Fibrosis Trust Wolfson Foundation

Nick Morrell (@nickmorrell15) 's Twitter Profile Photo

ATP13A3 variants promote pulmonary arterial hypertension by disrupting polyamine transport academic.oup.com/cardiovascres/… Great to see this out. Wonderful collaboration with Peter Vangheluwe and team!